Investing.com -- Here is a summary of the most important regulatory news releases from the London Stock Exchange on Friday, 20th December. Please refresh for updates.
- Royal Dutch Shell (LON:RDSa) (AS:RDSa) raised its forecast for oil production in the current quarter, saying output will be in a range between 2.775 million and 2.825 million barrels a day. The midpoint of that range is the very top end of the range it had forecast three months ago.
- AstraZeneca (LON:AZN) said it will sell the commercial rights to its breast and prostate cancer drugs Arimidex (anastrozole) and Casodex (bicalutamide) in a number of European, African and other countries1 to Juvisé Pharmaceuticals, for an up-front payment of $181 million.
- Juvise will pay up to an additional $17 million contingent on future sales of the drugs, which have lost their patent protection.
- “Today's agreement is part of a broader strategy of reducing our portfolio of mature medicines to reallocate resources towards developing our pipeline of new medicines," said oncology head Dave Fredrickson.